Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1995 1
1996 3
1997 2
1998 3
2002 3
2003 3
2004 4
2005 2
2006 5
2007 3
2008 5
2009 2
2012 2
2013 1
2014 1
2019 3
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.
Yeh MT, Bujaki E, Dolan PT, Smith M, Wahid R, Konz J, Weiner AJ, Bandyopadhyay AS, Van Damme P, De Coster I, Revets H, Macadam A, Andino R. Yeh MT, et al. Among authors: revets h. Cell Host Microbe. 2020 May 13;27(5):736-751.e8. doi: 10.1016/j.chom.2020.04.003. Epub 2020 Apr 23. Cell Host Microbe. 2020. PMID: 32330425 Free PMC article. Clinical Trial.
Poliopolis.
Van Damme P, De Coster I, Revets H, Bandyopadhyay AS. Van Damme P, et al. Among authors: revets h. Lancet. 2019 Jul 13;394(10193):115. doi: 10.1016/S0140-6736(19)31516-8. Epub 2019 Jul 11. Lancet. 2019. PMID: 31305249 No abstract available.
Nanobodies as novel agents for cancer therapy.
Revets H, De Baetselier P, Muyldermans S. Revets H, et al. Expert Opin Biol Ther. 2005 Jan;5(1):111-24. doi: 10.1517/14712598.5.1.111. Expert Opin Biol Ther. 2005. PMID: 15709914 Review.
Radioimmunoimaging. Advances and prospects.
Van de Wiele C, Revets H, Mertens N. Van de Wiele C, et al. Among authors: revets h. Q J Nucl Med Mol Imaging. 2004 Dec;48(4):317-25. Q J Nucl Med Mol Imaging. 2004. PMID: 15640795 Free article. Review.
Poliopolis: pushing boundaries of scientific innovations for disease eradication.
Van Damme P, Coster I, Bandyopadhyay AS, Suykens L, Rudelsheim P, Neels P, Oberste MS, Weldon WC, Clemens R, Revets H. Van Damme P, et al. Among authors: revets h. Future Microbiol. 2019 Oct;14:1321-1330. doi: 10.2217/fmb-2019-0196. Epub 2019 Sep 4. Future Microbiol. 2019. PMID: 31482728 Free PMC article. Clinical Trial.
Camelid immunoglobulins and nanobody technology.
Muyldermans S, Baral TN, Retamozzo VC, De Baetselier P, De Genst E, Kinne J, Leonhardt H, Magez S, Nguyen VK, Revets H, Rothbauer U, Stijlemans B, Tillib S, Wernery U, Wyns L, Hassanzadeh-Ghassabeh G, Saerens D. Muyldermans S, et al. Among authors: revets h. Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):178-83. doi: 10.1016/j.vetimm.2008.10.299. Epub 2008 Oct 17. Vet Immunol Immunopathol. 2009. PMID: 19026455
Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody.
Pruszynski M, Koumarianou E, Vaidyanathan G, Revets H, Devoogdt N, Lahoutte T, Zalutsky MR. Pruszynski M, et al. Among authors: revets h. Nucl Med Biol. 2013 Jan;40(1):52-9. doi: 10.1016/j.nucmedbio.2012.08.008. Epub 2012 Nov 15. Nucl Med Biol. 2013. PMID: 23159171 Free PMC article.
Efficient cancer therapy with a nanobody-based conjugate.
Cortez-Retamozo V, Backmann N, Senter PD, Wernery U, De Baetselier P, Muyldermans S, Revets H. Cortez-Retamozo V, et al. Among authors: revets h. Cancer Res. 2004 Apr 15;64(8):2853-7. doi: 10.1158/0008-5472.can-03-3935. Cancer Res. 2004. PMID: 15087403
42 results